The American Journal of Managed Care2d
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD
The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...
Rolling Out12d
How semaglutide is transforming kidney disease treatment
Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...
RFK Jr. fields pharma questions on Day Two
After two days of making his case to Senate committees, Robert F. Kennedy Jr.’s bid to lead federal health agencies still ...
15 Press Releases You Need to See This Week
With thousands of press releases published each week, it can be difficult to keep up with everything on . To help journalists ...
Irish Examiner1d
Inquest finds Cork grandmother died of total organ failure three months after starting on Ozempic
Pathologist Dr Margot Bolster said Breeda O’Donoghue's death should be referred to the Health Products Regulatory Authority ...
pharmaphorum6h
Two more biotechs, Metsera and Maze, cross IPO finish line
Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...
The American Journal of Managed Care1d
Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications
Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...